Check out the episode below, then read on to learn all about the difference between Semaglutide and Tirzepatide
and J-S.A.), I-SITE ULNE (EpiRNAdiab Sustain grant to J-S.A.), Conseil Rgional Hauts de France and Mtropole Europenne de Lille (to J-S.A.), F.E.D.E.R
The dosing path differs by indication
According to Cure's January 2025 patient survey white paper, side effects from taking GLP-1s were common but typically manageable
Semaglutide has been studied for over five years and is proven safe and effective both for individuals with type 2 diabetes and for those with obesity or who are overweight
While they may sound similar, these two approaches are quite different, especially in terms of invasiveness, cost, recovery, and results